Understanding the experiences of lung cancer patients and their caregivers
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
This study is trying to understand how lung cancer patients and their caregivers feel about their diagnosis and treatment by having them fill out monthly surveys for a year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | LUNGevity Foundation Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT05826756 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather insights from lung cancer patients and their caregivers about their experiences with diagnosis and treatment. Participants will complete monthly surveys over a 12-month period to assess the impact of various therapies on their quality of life and overall well-being. The study is designed to collect longitudinal data that will help identify factors influencing treatment experiences and outcomes. It is conducted by the LUNGevity Foundation and is compliant with ethical standards and data protection regulations.
Who should consider this trial
Good fit: Ideal candidates include adults diagnosed with lung cancer or caregivers of lung cancer patients who can read and respond to surveys in English.
Not a fit: Patients who are younger than 18 or healthcare professionals providing care to lung cancer patients may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of lung cancer treatment impacts, leading to improved patient care and support.
How similar studies have performed: Other studies focusing on patient-reported outcomes in cancer care have shown success, indicating that this approach is both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with self-reported lung cancer diagnosis or caregiver of someone with a self-reported lung cancer diagnosis (patient has to be alive) * Ability to read and answer questions in English * Access and ability to use a computer or other internet-connected device Exclusion Criteria: * Younger than 18 * Healthcare providers and healthcare professionals who provide care to lung cancer patients except for those who are themselves a patient or a caregiver to a loved one. * Not able to provide informed consent
Where this trial is running
Bethesda, Maryland
- LUNGevity Foundation — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Upal Basu Roy, PhD, MPH — LUNGevity Foundation
- Study coordinator: Tracey Grant, MS
- Email: ProjectPEER@lungevity.org
- Phone: (312) 519-1322
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.